Journal · Updated 2026-08-11
SkinnyRx Review 2026: $199/$299, Ad Matching Checkout, Mid-Tier by Choice
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
Short answer — August 2026
One ninety-nine semaglutide, two ninety-nine tirzepatide, all-in, stated — SkinnyRx earns its place in the ad-matches-checkout cluster, provider-stated status, no ladder gymnastics. Placement is equally clean: seventy over the semaglutide floor, a hundred-twenty-to-one-thirty over the tirzepatide flat tier — mid-market by choice, without the bundled programming that justifies Mochi-tier premiums. The review therefore reduces to the clinic-premium test and one intake question.
Placement and the question
What the premium buys isn't itemized in our records the way Mochi's dietitians or Enhance's labs are — which makes the intake question do the work: what's included that the one twenty-nine-to-one seventy-nine programs don't include, and which pharmacy fills my prescription? Strong answers (real provider cadence, responsive support, a nameable verified pharmacy) make the premium a service purchase; generic ones make it seventy-to-one-thirty a month for the same vial. At two ninety-nine tirzepatide, the standing note applies: FDA-approved Zepbound's own ladder starts at two ninety-nine, which means SkinnyRx's tirzepatide price meets the brand's entry rung head-on — a comparison the compounded side rarely survives on certainty per dollar. Verdict: a legible, honestly-priced mid-tier whose case must be made in its answers, because its numbers don't make it alone.
Questions people ask
How much is SkinnyRx?
$199/month for compounded semaglutide and $299 for tirzepatide, all-in, with the advertised price matching checkout (provider-stated status). No term ladder or membership line in our records.
Is SkinnyRx worth it over cheaper programs?
That's the intake question: at $70–$130/month over the $129–$179 tier, the premium needs a service answer (provider cadence, support, verified pharmacy) our records don't itemize. Ask what's included that the floor programs lack — and note $299 tirzepatide exactly meets FDA-approved Zepbound's $299 starter-vial rung.
Does SkinnyRx name its pharmacy?
Not in our public records — the standard intake extraction applies: get the name, then run the license lookups, FDA compounding records, and COA request. One message, fifteen minutes.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.